T2 Biosystems Cuts Product Revenue Guidance From $16M-$18M, Driven By T2SARS-CoV-2 Panel Sales
2021 Financial Outlook
The Company continues to expect revenue for the full year 2021 to be between $24.0 million and $26.0 million. Product revenue is now expected to be between $14.0 million and $15.0 million, compared